Company Overview

Update
Headquarters:
Ramat Gan
IPO:
Went Public on Jan 7, 2013
Stock:
NASDAQ:RDHL
Categories:
Biotechnology

RedHill Biopharma is focused primarily on the acquisition and development of late clinical-stage formulations of existing drugs.

Description

Update

RedHill Biopharma, established in 2009, is a pharmaceutical company focused primarily on acquisition and development of late clinical-stage new, improved and patented formulations of existing drugs, with preference to a 505(b)(2)* regulatory paths, as well as acquisition and developement of late clinical-stage, new and patented orphan drugs.

Current Team (1)

Update

Funding Rounds (3) - $30.20M

Update

Investors (6)

Update

Offices/Locations (1)

Update
  • Office

    42 Givati St.

    Ramat Gan, 52232

    ISR